METRONIDAZOLE

METRONIDAZOLE was reported 64304 times

METRONIDAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 251 0.8284
1 APPENDICOLITH 294 0.7597
2 SLEEP DISORDER THERAPY 137 0.6919
3 ANTACID THERAPY 87 0.6692
4 ANALGESIC THERAPY 133 0.4143
5 DRUG THERAPY 121 0.3569
6 ANTICOAGULANT THERAPY 85 0.2993
7 CONGENITAL HIATUS HERNIA 58 0.2544
8 BACTEROIDES INFECTION 53 0.2031
9 FEMALE GENITAL TRACT FISTULA 322 0.1884
10 TOXIC ENCEPHALOPATHY 673 0.1327
11 DYSMETRIA 71 0.1175
12 CEREBELLAR ATAXIA 106 0.1106
13 PSEUDOMEMBRANOUS COLITIS 247 0.1105
14 RADICULOPATHY 286 0.1084
15 PROCTITIS 300 0.1070
16 POUCHITIS 88 0.1022
17 CEREBELLAR SYNDROME 219 0.0999
18 BLOODY DISCHARGE 114 0.0997
19 FISTULA DISCHARGE 111 0.0879
20 HYPERPHOSPHATAEMIA 182 0.0846
21 CHRONIC SINUSITIS 314 0.0836
22 INTERNATIONAL NORMALISED RATIO FLUCTUATION 163 0.0787
23 CLOSTRIDIUM DIFFICILE COLITIS 830 0.0782
24 MEGACOLON 122 0.0776
25 ABORTION INCOMPLETE 140 0.0751
26 BLOOD PHOSPHORUS INCREASED 203 0.0743
27 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 68 0.0734
28 MACULAR DEGENERATION 862 0.0721
29 CLOSTRIDIUM COLITIS 87 0.0717
30 PELVIC ABSCESS 80 0.0696
31 ENTEROCUTANEOUS FISTULA 60 0.0680
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 68 0.0640
33 CLOSTRIDIUM TEST POSITIVE 141 0.0639
34 DYSBIOSIS 51 0.0621
35 PERIRECTAL ABSCESS 68 0.0613
36 ANAL FISTULA 319 0.0597
37 RECTAL ABSCESS 100 0.0596
38 BACTERIAL VAGINOSIS 92 0.0588
39 CLOSTRIDIUM DIFFICILE INFECTION 1185 0.0542
40 PATHOGEN RESISTANCE 493 0.0540
41 CLOSTRIDIAL INFECTION 180 0.0532
42 PELVIC INFLAMMATORY DISEASE 79 0.0529
43 LINEAR IGA DISEASE 88 0.0529
44 ACINETOBACTER INFECTION 57 0.0521
45 TOTAL LUNG CAPACITY DECREASED 82 0.0513
46 FIXED ERUPTION 88 0.0511
47 HYPERPARATHYROIDISM SECONDARY 128 0.0510
48 IRON DEFICIENCY 226 0.0502
49 NEPHROGENIC ANAEMIA 232 0.0500
50 VANISHING BILE DUCT SYNDROME 55 0.0493
51 ANAL ABSCESS 264 0.0489
52 LARGE INTESTINE INFECTION 60 0.0488
53 FISTULA 536 0.0476
54 ANAL FISSURE 250 0.0466
55 ABSCESS INTESTINAL 99 0.0459
56 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 342 0.0440
57 APPENDICITIS 408 0.0436
58 ENTEROCOLITIS HAEMORRHAGIC 63 0.0425
59 GASTROINTESTINAL WALL THICKENING 63 0.0421
60 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 61 0.0420
61 TONGUE COATED 72 0.0417
62 ABDOMINAL ABSCESS 173 0.0391
63 NEUROTOXICITY 643 0.0367
64 REBOUND ACID HYPERSECRETION 111 0.0367
65 VAGINAL DISCHARGE 358 0.0353
66 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 176 0.0347
67 ORAL CANDIDIASIS 457 0.0347
68 ENTEROCOCCAL INFECTION 164 0.0339
69 LYME DISEASE 113 0.0339
70 BRAIN ABSCESS 85 0.0336
71 KOUNIS SYNDROME 76 0.0334
72 ANORECTAL DISORDER 66 0.0331
73 ATAXIA 387 0.0326
74 BILIARY DYSKINESIA 55 0.0324
75 VENTRICULAR FIBRILLATION 356 0.0320
76 DIVERTICULAR PERFORATION 65 0.0316
77 BLOOD URIC ACID INCREASED 182 0.0315
78 CROHN'S DISEASE 215 0.0313
79 END STAGE RENAL DISEASE 566 0.0310
80 RASH MORBILLIFORM 86 0.0310
81 NEUTROPENIC COLITIS 64 0.0309
82 AORTIC STENOSIS 107 0.0307
83 HYPOPHOSPHATAEMIA 225 0.0304
84 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 780 0.0303
85 ROSACEA 140 0.0300
86 COLITIS 1139 0.0300
87 ABSCESS 456 0.0286
88 CHOLECYSTITIS CHRONIC 190 0.0284
89 FAECAL CALPROTECTIN INCREASED 89 0.0281
90 LIVER ABSCESS 91 0.0280
91 MULTIPLE ORGAN DYSFUNCTION SYNDROME 794 0.0280
92 DRUG LEVEL BELOW THERAPEUTIC 152 0.0275
93 LUNG OPACITY 72 0.0273
94 KLEBSIELLA INFECTION 137 0.0271
95 CHOLESTATIC LIVER INJURY 60 0.0269
96 TOXIC EPIDERMAL NECROLYSIS 407 0.0268
97 ILEOSTOMY 68 0.0266
98 CARDIOGENIC SHOCK 382 0.0266
99 PROCTALGIA 168 0.0261
100 MYASTHENIA GRAVIS 211 0.0261
101 PLEURITIC PAIN 71 0.0257
102 PARAESTHESIA ORAL 369 0.0256
103 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 57 0.0255
104 SYSTEMIC CANDIDA 64 0.0255
105 LONG QT SYNDROME 60 0.0250
106 DIVERTICULITIS 666 0.0240
107 ENCEPHALOPATHY 584 0.0238
108 NYSTAGMUS 125 0.0235
109 RETROPERITONEAL HAEMATOMA 52 0.0235
110 TYPE IV HYPERSENSITIVITY REACTION 63 0.0230
111 HAEMOLYTIC URAEMIC SYNDROME 52 0.0224
112 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 59 0.0222
113 CYTOMEGALOVIRUS COLITIS 51 0.0222
114 DIVERTICULUM INTESTINAL 96 0.0219
115 CHOLESTASIS 415 0.0216
116 RASH MACULO-PAPULAR 466 0.0209
117 LARGE INTESTINE PERFORATION 145 0.0209
118 HYPERLIPIDAEMIA 249 0.0208
119 CHOLECYSTITIS ACUTE 118 0.0208
120 VAGINAL INFECTION 98 0.0208
121 BACTERIAL INFECTION 388 0.0208
122 COLITIS ISCHAEMIC 139 0.0206
123 DERMATITIS EXFOLIATIVE 103 0.0206
124 BONE EROSION 72 0.0203
125 DIVERTICULUM 144 0.0202
126 MUCOUS STOOLS 100 0.0202
127 SEPTIC SHOCK 870 0.0200
128 RENAL TUBULAR NECROSIS 196 0.0200
129 TENOSYNOVITIS 55 0.0199
130 TONGUE DISCOLOURATION 87 0.0199
131 HAEMODYNAMIC INSTABILITY 151 0.0198
132 PYODERMA GANGRENOSUM 71 0.0197
133 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 64 0.0197
134 HEPATIC NECROSIS 74 0.0196
135 ASCITES 577 0.0196
136 ABDOMINAL TENDERNESS 97 0.0195
137 INTESTINAL STENOSIS 82 0.0194
138 HEPATIC CYST 66 0.0194
139 BENIGN PROSTATIC HYPERPLASIA 100 0.0193
140 FREQUENT BOWEL MOVEMENTS 518 0.0192
141 DRUG LEVEL ABOVE THERAPEUTIC 87 0.0190
142 PERIPHERAL SENSORY NEUROPATHY 111 0.0190
143 DIARRHOEA HAEMORRHAGIC 175 0.0187
144 AGRANULOCYTOSIS 347 0.0187
145 ATELECTASIS 179 0.0185
146 ERYTHEMA NODOSUM 65 0.0185
147 VENOOCCLUSIVE LIVER DISEASE 91 0.0184
148 ECONOMIC PROBLEM 274 0.0181
149 TROPONIN INCREASED 137 0.0180
150 EOSINOPHILIA 313 0.0178
151 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 68 0.0178
152 RENAL CYST 141 0.0177
153 TUBULOINTERSTITIAL NEPHRITIS 330 0.0176
154 BREATH SOUNDS ABNORMAL 86 0.0174
155 CHRONIC KIDNEY DISEASE 1320 0.0174
156 ENTEROCOLITIS 100 0.0173
157 DERMATITIS EXFOLIATIVE GENERALISED 60 0.0172
158 CHROMATURIA 388 0.0172
159 LEUKOCYTOSIS 310 0.0171
160 ENTERITIS 109 0.0170
161 DEAFNESS NEUROSENSORY 56 0.0170
162 HEPATITIS CHOLESTATIC 102 0.0169
163 PSEUDOMONAS INFECTION 145 0.0169
164 SUBCUTANEOUS ABSCESS 81 0.0169
165 SMALL INTESTINAL OBSTRUCTION 205 0.0166
166 WOUND SECRETION 65 0.0166
167 BACTERAEMIA 196 0.0165
168 TORSADE DE POINTES 127 0.0162
169 NECROTISING FASCIITIS 57 0.0162
170 VASCULAR DEVICE INFECTION 73 0.0161
171 HAEMATOCHEZIA 884 0.0160
172 RECTAL HAEMORRHAGE 686 0.0160
173 CANDIDIASIS 64 0.0159
174 LEUKOENCEPHALOPATHY 59 0.0158
175 SYNOVIAL CYST 73 0.0158
176 TOXIC SKIN ERUPTION 159 0.0158
177 ACUTE HEPATIC FAILURE 213 0.0156
178 ASPERGILLUS INFECTION 101 0.0154
179 GASTROINTESTINAL INFLAMMATION 120 0.0153
180 MALNUTRITION 171 0.0153
181 HYPERREFLEXIA 53 0.0152
182 SWOLLEN TONGUE 474 0.0152
183 UTERINE PERFORATION 128 0.0151
184 APHTHOUS ULCER 117 0.0151
185 ANHEDONIA 396 0.0151
186 THROMBOTIC THROMBOCYTOPENIC PURPURA 53 0.0150
187 CANDIDA INFECTION 254 0.0150
188 ABSCESS LIMB 64 0.0150
189 STAPHYLOCOCCAL SEPSIS 74 0.0150
190 BONE LESION 54 0.0150
191 HEPATOCELLULAR INJURY 212 0.0149
192 PANCREATITIS ACUTE 335 0.0149
193 ESCHERICHIA INFECTION 122 0.0148
194 HYPOVOLAEMIC SHOCK 71 0.0148
195 JAUNDICE CHOLESTATIC 52 0.0147
196 HYPOALBUMINAEMIA 114 0.0146
197 OLIGURIA 91 0.0146
198 CHOLECYSTITIS 174 0.0146
199 SPINAL OSTEOARTHRITIS 128 0.0146
200 DISSEMINATED INTRAVASCULAR COAGULATION 205 0.0145
201 COLITIS ULCERATIVE 649 0.0145
202 HALLUCINATIONS, MIXED 61 0.0145
203 HELICOBACTER INFECTION 148 0.0144
204 LIPASE INCREASED 110 0.0143
205 HEPATITIS 366 0.0143
206 BRONCHIECTASIS 96 0.0142
207 PROCEDURAL PAIN 391 0.0141
208 GASTROENTERITIS 205 0.0140
209 ULCER 223 0.0140
210 LOW BIRTH WEIGHT BABY 111 0.0140
211 GASTROINTESTINAL INFECTION 125 0.0139
212 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 133 0.0139
213 DYSARTHRIA 523 0.0139
214 PROTHROMBIN TIME PROLONGED 83 0.0139
215 INTERNATIONAL NORMALISED RATIO INCREASED 395 0.0138
216 HYPERNATRAEMIA 69 0.0138
217 SEPSIS 1532 0.0137
218 MULTI-ORGAN FAILURE 237 0.0137
219 HEPATITIS ACUTE 89 0.0137
220 RASH PUSTULAR 99 0.0136
221 HEPATOMEGALY 132 0.0134
222 RALES 78 0.0134
223 HEPATIC CYTOLYSIS 171 0.0134
224 COAGULOPATHY 223 0.0134
225 BLOOD ALBUMIN DECREASED 106 0.0133
226 PURULENT DISCHARGE 57 0.0133
227 LARGE INTESTINE POLYP 92 0.0133
228 INTESTINAL PERFORATION 149 0.0133
229 HEPARIN-INDUCED THROMBOCYTOPENIA 65 0.0132
230 DERMATITIS BULLOUS 95 0.0131
231 ABDOMINAL PAIN 3048 0.0131
232 METABOLIC ACIDOSIS 414 0.0129
233 NECROSIS 72 0.0129
234 NEURALGIA 314 0.0129
235 IMMUNE THROMBOCYTOPENIA 59 0.0129
236 TRICUSPID VALVE INCOMPETENCE 102 0.0128
237 PERIPHERAL VASCULAR DISORDER 66 0.0128
238 INTESTINAL ISCHAEMIA 70 0.0127
239 HIATUS HERNIA 164 0.0127
240 APLASTIC ANAEMIA 66 0.0126
241 POLYNEUROPATHY 151 0.0126
242 NEUROLOGICAL SYMPTOM 72 0.0126
243 ILEUS PARALYTIC 56 0.0125
244 BLOOD CALCIUM INCREASED 110 0.0125
245 HYPOVOLAEMIA 73 0.0125
246 ARTERIOSPASM CORONARY 50 0.0125
247 STAPHYLOCOCCAL INFECTION 411 0.0124
248 HYPERCHOLESTEROLAEMIA 120 0.0124
249 SPRUE-LIKE ENTEROPATHY 61 0.0124
250 ACUTE KIDNEY INJURY 1873 0.0122
251 ABNORMAL FAECES 100 0.0122
252 HAEMORRHOIDS 238 0.0122
253 GASTROINTESTINAL SOUNDS ABNORMAL 60 0.0121
254 DRUG LEVEL DECREASED 123 0.0121
255 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 207 0.0121
256 NEUTROPENIC SEPSIS 86 0.0120
257 GINGIVAL SWELLING 53 0.0120
258 COMPRESSION FRACTURE 63 0.0117
259 ABDOMINAL PAIN LOWER 296 0.0117
260 TENDONITIS 181 0.0117
261 GRAFT VERSUS HOST DISEASE 84 0.0117
262 TENDON DISORDER 76 0.0116
263 RHEUMATOID FACTOR POSITIVE 67 0.0116
264 HYPERBILIRUBINAEMIA 120 0.0116
265 RENAL FAILURE CHRONIC 89 0.0116
266 RED BLOOD CELL SEDIMENTATION RATE INCREASED 128 0.0116
267 FAILURE TO THRIVE 60 0.0115
268 RENAL FAILURE 1532 0.0115
269 ANAPHYLACTIC REACTION 636 0.0115
270 MITRAL VALVE INCOMPETENCE 130 0.0115
271 ABORTION SPONTANEOUS 460 0.0115
272 OSTEOPENIA 174 0.0115
273 POOR VENOUS ACCESS 118 0.0114
274 ELECTROLYTE IMBALANCE 131 0.0113
275 HYPONATRAEMIA 635 0.0113
276 STEVENS-JOHNSON SYNDROME 249 0.0112
277 ANGIOEDEMA 495 0.0112
278 ILEUS 139 0.0112
279 SKIN NECROSIS 58 0.0112
280 CHOLELITHIASIS 366 0.0111
281 INTESTINAL RESECTION 60 0.0111
282 DRUG SPECIFIC ANTIBODY PRESENT 72 0.0111
283 HEPATIC FAILURE 333 0.0110
284 TENDON PAIN 83 0.0110
285 TENDERNESS 114 0.0109
286 GOUT 196 0.0109
287 MENTAL STATUS CHANGES 303 0.0109
288 JAUNDICE 292 0.0108
289 C-REACTIVE PROTEIN INCREASED 394 0.0108
290 INTERVERTEBRAL DISC DEGENERATION 100 0.0108
291 PREMATURE LABOUR 61 0.0108
292 LUNG INFILTRATION 95 0.0107
293 BLOOD ALKALINE PHOSPHATASE INCREASED 267 0.0107
294 OSTEOMYELITIS 193 0.0106
295 VULVOVAGINAL PAIN 51 0.0106
296 ANURIA 91 0.0106
297 HYPOKALAEMIA 486 0.0105
298 PLATELET COUNT INCREASED 137 0.0105
299 ABDOMINAL DISTENSION 1093 0.0105
300 ACIDOSIS 80 0.0105
301 DYSLIPIDAEMIA 53 0.0104
302 TACHYPNOEA 141 0.0104
303 RENAL FAILURE ACUTE 438 0.0103
304 ASPIRATION 113 0.0103
305 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 77 0.0103
306 PANCYTOPENIA 573 0.0102
307 HYPERTHERMIA 78 0.0102
308 BLOOD BILIRUBIN INCREASED 276 0.0102
309 TOOTH ABSCESS 104 0.0102
310 IRON DEFICIENCY ANAEMIA 94 0.0102
311 SWELLING FACE 662 0.0102
312 NEPHROPATHY TOXIC 114 0.0101
313 DRUG-INDUCED LIVER INJURY 318 0.0101
314 MOUTH ULCERATION 212 0.0101
315 PELVIC PAIN 182 0.0100
316 LIVER FUNCTION TEST ABNORMAL 291 0.0100
317 SINUS TACHYCARDIA 142 0.0100
318 CARDIOMEGALY 123 0.0100
319 SKIN WARM 58 0.0100
320 INJURY 698 0.0099
321 PETECHIAE 103 0.0099
322 MUCOSAL INFLAMMATION 258 0.0098
323 PLEURAL EFFUSION 599 0.0098
324 APPETITE DISORDER 65 0.0098
325 DRUG RESISTANCE 251 0.0098
326 HYPOXIA 343 0.0097
327 DRUG INTOLERANCE 938 0.0097
328 STREPTOCOCCAL INFECTION 54 0.0097
329 ENCEPHALITIS 67 0.0097
330 TOOTH INFECTION 127 0.0096
331 GALLBLADDER DISORDER 171 0.0096
332 DEFAECATION URGENCY 67 0.0096
333 NEUROPATHY PERIPHERAL 909 0.0095
334 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 524 0.0095
335 GAMMA-GLUTAMYLTRANSFERASE INCREASED 211 0.0095
336 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 676 0.0095
337 PURPURA 84 0.0095
338 HAEMOLYTIC ANAEMIA 85 0.0095
339 PYREXIA 3278 0.0095
340 PREMATURE DELIVERY 150 0.0094
341 OVARIAN CYST 94 0.0094
342 FULL BLOOD COUNT ABNORMAL 99 0.0094
343 POSTOPERATIVE WOUND INFECTION 63 0.0093
344 RENAL INJURY 277 0.0093
345 SENSORY LOSS 75 0.0093
346 CYTOMEGALOVIRUS INFECTION 154 0.0093
347 ERYTHEMA MULTIFORME 86 0.0092
348 C-REACTIVE PROTEIN ABNORMAL 59 0.0092
349 MICTURITION URGENCY 105 0.0092
350 EAR PAIN 178 0.0091
351 ORAL DISORDER 67 0.0091
352 MYOCLONUS 109 0.0091
353 PREMATURE BABY 275 0.0091
354 ACUTE RESPIRATORY DISTRESS SYNDROME 161 0.0091
355 RESPIRATORY FAILURE 660 0.0090
356 DEVICE RELATED INFECTION 139 0.0090
357 BRONCHOPULMONARY ASPERGILLOSIS 70 0.0090
358 ANAEMIA 1720 0.0090
359 SKIN ULCER 233 0.0090
360 POLYP 59 0.0090
361 BLOOD PRESSURE FLUCTUATION 216 0.0090
362 POST PROCEDURAL INFECTION 73 0.0090
363 FLANK PAIN 84 0.0090
364 VASCULITIS 104 0.0089
365 NIGHT SWEATS 287 0.0089
366 ASPARTATE AMINOTRANSFERASE INCREASED 473 0.0089
367 DERMATITIS ALLERGIC 112 0.0089
368 ANAL INCONTINENCE 80 0.0089
369 GENERALISED OEDEMA 110 0.0089
370 DEFORMITY 83 0.0089
371 RESPIRATORY DISTRESS 244 0.0088
372 DECUBITUS ULCER 72 0.0088
373 INTESTINAL OBSTRUCTION 333 0.0088
374 FAECES SOFT 64 0.0088
375 INFLAMMATORY BOWEL DISEASE 86 0.0088
376 HIDRADENITIS 80 0.0088
377 UTERINE LEIOMYOMA 64 0.0087
378 LEUKOPENIA 437 0.0087
379 ACUTE RESPIRATORY FAILURE 168 0.0087
380 SECRETION DISCHARGE 109 0.0087
381 CARDIAC MURMUR 75 0.0087
382 CARDIAC FLUTTER 56 0.0087
383 PERITONITIS 179 0.0086
384 BLOOD TEST ABNORMAL 121 0.0086
385 OESOPHAGITIS 94 0.0086
386 COORDINATION ABNORMAL 120 0.0086
387 FUNGAL INFECTION 285 0.0085
388 BLOOD PRESSURE DIASTOLIC DECREASED 63 0.0085
389 SHOCK 196 0.0085
390 ARTERIOSCLEROSIS 80 0.0085
391 PAROSMIA 64 0.0085
392 GENERAL PHYSICAL HEALTH DETERIORATION 981 0.0085
393 THROMBOCYTOPENIA 947 0.0085
394 ECCHYMOSIS 58 0.0085
395 PULMONARY MASS 126 0.0085
396 UROSEPSIS 78 0.0084
397 PYELONEPHRITIS 73 0.0084
398 BLEPHAROSPASM 53 0.0084
399 MELAENA 185 0.0084
400 WHITE BLOOD CELL COUNT INCREASED 322 0.0084
401 VENTRICULAR TACHYCARDIA 138 0.0083
402 SUPRAVENTRICULAR TACHYCARDIA 80 0.0083
403 FEBRILE NEUTROPENIA 554 0.0083
404 HYPOPHAGIA 213 0.0083
405 MULTIPLE INJURIES 52 0.0083
406 SCAR 141 0.0082
407 CHOLECYSTECTOMY 93 0.0081
408 DRUG INTERACTION 1291 0.0081
409 PULMONARY EMBOLISM 769 0.0081
410 OSTEONECROSIS OF JAW 200 0.0081
411 TACHYCARDIA 718 0.0081
412 DUODENAL ULCER 57 0.0081
413 IRRITABLE BOWEL SYNDROME 173 0.0081
414 ANAPHYLACTIC SHOCK 208 0.0081
415 DENTAL CARIES 89 0.0080
416 ELECTROCARDIOGRAM QT PROLONGED 289 0.0080
417 MANIA 132 0.0080
418 NERVOUS SYSTEM DISORDER 250 0.0080
419 SHOCK HAEMORRHAGIC 65 0.0080
420 VITAMIN D DECREASED 68 0.0079
421 HEPATIC ENCEPHALOPATHY 74 0.0079
422 GENERALISED TONIC-CLONIC SEIZURE 131 0.0079
423 BONE DISORDER 144 0.0079
424 PHARYNGITIS 98 0.0079
425 ORAL PAIN 176 0.0079
426 INFUSION RELATED REACTION 520 0.0078
427 FACIAL PAIN 70 0.0078
428 OEDEMA 425 0.0078
429 TRANSAMINASES INCREASED 174 0.0078
430 SKIN LESION 214 0.0078
431 MENINGITIS 52 0.0078
432 LEFT VENTRICULAR DYSFUNCTION 52 0.0078
433 ALANINE AMINOTRANSFERASE INCREASED 475 0.0077
434 DRUG ERUPTION 137 0.0077
435 DYSGEUSIA 574 0.0077
436 FAECES DISCOLOURED 167 0.0077
437 CELLULITIS 385 0.0076
438 GASTRITIS 201 0.0076
439 DYSPEPSIA 747 0.0076
440 INTENTIONAL PRODUCT USE ISSUE 664 0.0076
441 DEEP VEIN THROMBOSIS 491 0.0075
442 SPUTUM DISCOLOURED 71 0.0075
443 VITAMIN D DEFICIENCY 73 0.0075
444 OSTEOARTHRITIS 317 0.0075
445 FACE OEDEMA 126 0.0075
446 SWELLING 697 0.0074
447 BOWEL MOVEMENT IRREGULARITY 57 0.0074
448 BURSITIS 90 0.0074
449 OSTEOPOROSIS 303 0.0074
450 WEIGHT FLUCTUATION 77 0.0074
451 PARAESTHESIA 1152 0.0073
452 URINE OUTPUT DECREASED 64 0.0073
453 EXPOSURE DURING PREGNANCY 454 0.0073
454 PHOTOPHOBIA 137 0.0073
455 HAEMODIALYSIS 61 0.0073
456 PRODUCT ADMINISTRATION INTERRUPTED 57 0.0073
457 HAEMATOTOXICITY 69 0.0073
458 PHARYNGEAL SWELLING 71 0.0072
459 SINUS BRADYCARDIA 70 0.0072
460 HEART RATE IRREGULAR 163 0.0072
461 HYDRONEPHROSIS 54 0.0072
462 BLOOD MAGNESIUM DECREASED 62 0.0072
463 SPLENOMEGALY 84 0.0072
464 CONDITION AGGRAVATED 2178 0.0072
465 GRAND MAL CONVULSION 66 0.0071
466 CONFUSIONAL STATE 1154 0.0071
467 INTERVERTEBRAL DISC PROTRUSION 156 0.0071
468 DRUG LEVEL INCREASED 118 0.0071
469 PNEUMOTHORAX 113 0.0071
470 VOMITING 3350 0.0071
471 BODY TEMPERATURE INCREASED 145 0.0071
472 DYSPHONIA 415 0.0071
473 DELIRIUM 246 0.0071
474 POLYURIA 58 0.0071
475 GASTROOESOPHAGEAL REFLUX DISEASE 569 0.0071
476 LOWER GASTROINTESTINAL HAEMORRHAGE 52 0.0070
477 HAEMATEMESIS 178 0.0070
478 PHARYNGEAL OEDEMA 108 0.0070
479 BLOOD CREATININE INCREASED 456 0.0070
480 LIGAMENT SPRAIN 69 0.0070
481 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 364 0.0070
482 LIP SWELLING 231 0.0069
483 CIRCULATORY COLLAPSE 118 0.0069
484 BODY TEMPERATURE DECREASED 68 0.0069
485 INFLAMMATION 355 0.0069
486 PANCREATITIS 361 0.0068
487 CYANOSIS 107 0.0068
488 ALTERED STATE OF CONSCIOUSNESS 147 0.0068
489 GINGIVAL PAIN 54 0.0068
490 CORONARY ARTERY DISEASE 205 0.0068
491 TINNITUS 311 0.0068
492 FEAR 182 0.0068
493 LIVER INJURY 166 0.0068
494 DISORIENTATION 267 0.0067
495 EYE INFECTION 76 0.0067
496 CONSTIPATION 1467 0.0067
497 HAEMATOCRIT DECREASED 133 0.0067
498 DEHYDRATION 891 0.0067
499 HYPOMAGNESAEMIA 93 0.0067
500 INFECTION 966 0.0067
501 DYSURIA 245 0.0066
502 SPINAL COMPRESSION FRACTURE 55 0.0066
503 RESPIRATORY RATE INCREASED 59 0.0066
504 HYPERKALAEMIA 233 0.0066
505 NEPHROPATHY 62 0.0066
506 ROTATOR CUFF SYNDROME 85 0.0066
507 NEUTROPENIA 895 0.0066
508 LYMPHADENOPATHY 233 0.0066
509 TREATMENT FAILURE 545 0.0066
510 PNEUMONIA ASPIRATION 164 0.0066
511 BLOOD CHOLESTEROL INCREASED 306 0.0066
512 SKIN LACERATION 71 0.0065
513 BRONCHOSPASM 93 0.0065
514 HYPOTONIA 65 0.0065
515 RASH ERYTHEMATOUS 310 0.0065
516 WEIGHT DECREASED 1810 0.0065
517 HEPATOTOXICITY 144 0.0065
518 IMPAIRED GASTRIC EMPTYING 88 0.0064
519 LOWER RESPIRATORY TRACT INFECTION 293 0.0064
520 HEPATIC STEATOSIS 120 0.0064
521 UNRESPONSIVE TO STIMULI 166 0.0064
522 PHOTOSENSITIVITY REACTION 106 0.0064
523 LIVER DISORDER 284 0.0064
524 DIARRHOEA 4131 0.0064
525 WOUND INFECTION 70 0.0064
526 DYSPHAGIA 606 0.0064
527 OBESITY 101 0.0063
528 BLOOD POTASSIUM DECREASED 190 0.0063
529 PAIN IN JAW 179 0.0063
530 HEART RATE DECREASED 221 0.0063
531 MYOCARDITIS 72 0.0063
532 LACTIC ACIDOSIS 203 0.0063
533 HYPOAESTHESIA 937 0.0063
534 PSYCHOLOGICAL TRAUMA 54 0.0063
535 SEROTONIN SYNDROME 120 0.0062
536 MUSCULOSKELETAL STIFFNESS 547 0.0062
537 ANXIETY 1776 0.0062
538 BLOOD CALCIUM DECREASED 70 0.0062
539 HYPOTENSION 1244 0.0062
540 ORAL HERPES 121 0.0062
541 APHASIA 186 0.0062
542 RASH GENERALISED 159 0.0061
543 TOOTHACHE 111 0.0061
544 CHILLS 718 0.0061
545 DECREASED ACTIVITY 66 0.0061
546 NERVE INJURY 68 0.0061
547 FLUID OVERLOAD 89 0.0061
548 HALLUCINATION, VISUAL 129 0.0061
549 MATERNAL EXPOSURE DURING PREGNANCY 543 0.0061
550 ATRIAL SEPTAL DEFECT 51 0.0061
551 GASTROINTESTINAL PAIN 67 0.0061
552 TOOTH FRACTURE 67 0.0061
553 RASH PAPULAR 136 0.0061
554 SKIN INFECTION 68 0.0061
555 LIVER FUNCTION TEST INCREASED 130 0.0060
556 NEUTROPHIL COUNT INCREASED 62 0.0060
557 THROMBOTIC MICROANGIOPATHY 59 0.0060
558 SLEEP APNOEA SYNDROME 115 0.0060
559 OBSTRUCTIVE AIRWAYS DISORDER 67 0.0060
560 GASTROINTESTINAL DISORDER 537 0.0060
561 HALLUCINATION, AUDITORY 95 0.0060
562 NAUSEA 4730 0.0060
563 EMOTIONAL DISTRESS 719 0.0059
564 FLATULENCE 336 0.0059
565 HALLUCINATION 446 0.0059
566 PARANOIA 102 0.0059
567 OEDEMA PERIPHERAL 721 0.0059
568 HYPERCALCAEMIA 73 0.0059
569 IMMUNOSUPPRESSION 52 0.0059
570 DRY MOUTH 478 0.0059
571 HEAD DISCOMFORT 104 0.0059
572 NECK PAIN 327 0.0058
573 ADRENAL INSUFFICIENCY 71 0.0058
574 PARKINSONISM 57 0.0058
575 STATUS EPILEPTICUS 66 0.0058
576 UPPER RESPIRATORY TRACT INFECTION 269 0.0058
577 BONE MARROW FAILURE 118 0.0058
578 EXOSTOSIS 53 0.0058
579 BLOOD PRESSURE SYSTOLIC INCREASED 113 0.0058
580 ERYTHEMA 1191 0.0058
581 BLOOD UREA INCREASED 97 0.0058
582 EJECTION FRACTION DECREASED 90 0.0058
583 ABDOMINAL PAIN UPPER 1190 0.0058
584 BLISTER 324 0.0058
585 CENTRAL NERVOUS SYSTEM LESION 79 0.0057
586 RASH MACULAR 201 0.0057
587 CYSTITIS 183 0.0057
588 BLOOD LACTATE DEHYDROGENASE INCREASED 91 0.0057
589 ANOREXIA 74 0.0057
590 RIB FRACTURE 118 0.0057
591 HAEMOPTYSIS 160 0.0057
592 BLOOD IRON DECREASED 68 0.0057
593 THROMBOSIS 461 0.0057
594 BLOOD SODIUM DECREASED 108 0.0057
595 MYOSITIS 51 0.0057
596 POST PROCEDURAL COMPLICATION 109 0.0057
597 DEAFNESS 148 0.0057
598 PALLOR 154 0.0057
599 IMPAIRED HEALING 185 0.0056
600 DERMATITIS 118 0.0056
601 HAEMOGLOBIN DECREASED 578 0.0056
602 BURNING SENSATION 394 0.0056
603 HAEMATOMA 145 0.0056
604 VENTRICULAR EXTRASYSTOLES 58 0.0056
605 CARDIO-RESPIRATORY ARREST 233 0.0056
606 CARDIAC ARREST 460 0.0056
607 FEEDING DISORDER 113 0.0056
608 IMPAIRED QUALITY OF LIFE 80 0.0056
609 HYPERSENSITIVITY 1026 0.0055
610 JOINT INJURY 118 0.0055
611 QUALITY OF LIFE DECREASED 74 0.0055
612 HYPOKINESIA 80 0.0055
613 MUSCLE TWITCHING 127 0.0055
614 RASH PRURITIC 298 0.0055
615 HAEMATURIA 188 0.0055
616 CYST 68 0.0055
617 PULMONARY FIBROSIS 105 0.0055
618 EMPHYSEMA 55 0.0054
619 JOINT RANGE OF MOTION DECREASED 73 0.0054
620 CARPAL TUNNEL SYNDROME 76 0.0054
621 FOETAL EXPOSURE DURING PREGNANCY 441 0.0054
622 PERIPHERAL COLDNESS 74 0.0054
623 PULMONARY CONGESTION 71 0.0054
624 VERTIGO 328 0.0054
625 GASTROINTESTINAL HAEMORRHAGE 448 0.0054
626 EATING DISORDER 114 0.0053
627 URINARY TRACT INFECTION 913 0.0053
628 CARDIOMYOPATHY 79 0.0053
629 ATRIAL FIBRILLATION 520 0.0053
630 THERAPY NON-RESPONDER 240 0.0053
631 URTICARIA 894 0.0053
632 WOUND 149 0.0053
633 HEMIPARESIS 90 0.0053
634 PANIC ATTACK 193 0.0053
635 MASS 74 0.0053
636 PHARYNGITIS STREPTOCOCCAL 57 0.0053
637 EAR DISCOMFORT 54 0.0053
638 EMBEDDED DEVICE 52 0.0052
639 PSYCHOTIC DISORDER 155 0.0052
640 SLEEP DISORDER 370 0.0052
641 PARALYSIS 75 0.0052
642 MUSCULOSKELETAL CHEST PAIN 81 0.0052
643 DRUG EXPOSURE DURING PREGNANCY 178 0.0052
644 HYPOCALCAEMIA 99 0.0052
645 ACUTE MYOCARDIAL INFARCTION 154 0.0052
646 DIABETES MELLITUS 398 0.0052
647 HEPATIC CIRRHOSIS 98 0.0052
648 LUNG INFECTION 81 0.0052
649 INCONTINENCE 55 0.0052
650 ACUTE MYELOID LEUKAEMIA 81 0.0052
651 PULMONARY HYPERTENSION 108 0.0052
652 TENDON RUPTURE 64 0.0052
653 RENAL IMPAIRMENT 431 0.0051
654 SKIN DISORDER 171 0.0051
655 METASTASES TO BONE 84 0.0051
656 RHABDOMYOLYSIS 211 0.0051
657 DECREASED APPETITE 1174 0.0050
658 LOCALISED INFECTION 122 0.0050
659 HYPOAESTHESIA ORAL 76 0.0050
660 LYMPHOPENIA 71 0.0050
661 UVEITIS 68 0.0050
662 FOOT FRACTURE 95 0.0050
663 PAIN 3075 0.0050
664 THINKING ABNORMAL 93 0.0050
665 LETHARGY 287 0.0050
666 HAEMORRHAGE 521 0.0050
667 FOOT DEFORMITY 55 0.0050
668 COMA 236 0.0050
669 SPEECH DISORDER 259 0.0049
670 NOCTURIA 60 0.0049
671 DRUG TOXICITY 67 0.0049
672 MUSCULAR WEAKNESS 557 0.0049
673 DYSTONIA 95 0.0049
674 CONVULSION 280 0.0049
675 DIPLOPIA 127 0.0049
676 FEELING COLD 136 0.0049
677 WRIST FRACTURE 58 0.0048
678 BRAIN OEDEMA 61 0.0048
679 OFF LABEL USE 4226 0.0048
680 EYELID OEDEMA 56 0.0048
681 CAESAREAN SECTION 56 0.0048
682 DEPRESSED LEVEL OF CONSCIOUSNESS 190 0.0048
683 GLOMERULAR FILTRATION RATE DECREASED 59 0.0048
684 PRESYNCOPE 116 0.0048
685 MUSCLE RIGIDITY 57 0.0048
686 DEPRESSION 1084 0.0048
687 ASTHENIA 1790 0.0048
688 NEPHROLITHIASIS 218 0.0047
689 CONJUNCTIVITIS 88 0.0047
690 GENITAL HAEMORRHAGE 61 0.0047
691 SINUS CONGESTION 64 0.0047
692 INFUSION SITE PAIN 61 0.0047
693 CRYING 172 0.0047
694 RESPIRATORY DEPRESSION 58 0.0047
695 BIPOLAR DISORDER 51 0.0047
696 WHEEZING 277 0.0047
697 PULMONARY OEDEMA 209 0.0047
698 PRODUCT USE IN UNAPPROVED INDICATION 1156 0.0047
699 HEADACHE 2922 0.0047
700 THROAT TIGHTNESS 126 0.0047
701 OROPHARYNGEAL PAIN 431 0.0047
702 ORTHOSTATIC HYPOTENSION 81 0.0046
703 PRODUCTIVE COUGH 222 0.0046
704 CARDIOVASCULAR DISORDER 118 0.0046
705 DYSPNOEA EXERTIONAL 175 0.0046
706 RESPIRATORY TRACT INFECTION 121 0.0046
707 MENTAL IMPAIRMENT 112 0.0046
708 SKIN REACTION 65 0.0046
709 HYPERGLYCAEMIA 168 0.0046
710 GAIT INABILITY 154 0.0046
711 SEASONAL ALLERGY 65 0.0046
712 MALAISE 2013 0.0046
713 LOCAL SWELLING 80 0.0046
714 CHEST PAIN 843 0.0045
715 TOOTH DISORDER 101 0.0045
716 GASTROENTERITIS VIRAL 82 0.0045
717 GAIT DISTURBANCE 866 0.0045
718 HEART RATE INCREASED 447 0.0045
719 NO THERAPEUTIC RESPONSE 55 0.0045
720 CHEST DISCOMFORT 461 0.0045
721 MUSCLE ATROPHY 57 0.0045
722 PREGNANCY 90 0.0045
723 RASH 1958 0.0045
724 SOMNOLENCE 904 0.0045
725 SYNCOPE 449 0.0045
726 BRONCHITIS 332 0.0045
727 MYOCARDIAL ISCHAEMIA 51 0.0045
728 RED BLOOD CELL COUNT DECREASED 128 0.0045
729 PROTEINURIA 85 0.0045
730 TREMOR 741 0.0045
731 LIMB DISCOMFORT 138 0.0045
732 MUSCULOSKELETAL PAIN 233 0.0044
733 METASTASES TO LIVER 78 0.0044
734 PRODUCT TASTE ABNORMAL 60 0.0044
735 SENSORY DISTURBANCE 71 0.0044
736 HYPERTENSION 937 0.0044
737 DIZZINESS 2199 0.0044
738 LUNG DISORDER 216 0.0044
739 BRAIN FOG 69 0.0044
740 ANGINA PECTORIS 126 0.0044
741 IMPAIRED WORK ABILITY 94 0.0044
742 SINUSITIS 449 0.0044
743 FEELING HOT 268 0.0044
744 BACK PAIN 1015 0.0044
745 PALPITATIONS 511 0.0044
746 URINARY INCONTINENCE 129 0.0043
747 MYALGIA 740 0.0043
748 HYPOGLYCAEMIA 211 0.0043
749 PERICARDIAL EFFUSION 100 0.0043
750 MENTAL DISORDER 188 0.0043
751 DYSKINESIA 175 0.0043
752 PNEUMONIA 1384 0.0043
753 RETCHING 91 0.0043
754 TOXICITY TO VARIOUS AGENTS 719 0.0043
755 HEPATIC ENZYME INCREASED 290 0.0042
756 THERAPEUTIC RESPONSE SHORTENED 141 0.0042
757 LYMPHOCYTE COUNT DECREASED 75 0.0042
758 RESTLESSNESS 155 0.0042
759 DRUG INEFFECTIVE 5574 0.0042
760 UPPER GASTROINTESTINAL HAEMORRHAGE 71 0.0042
761 EPILEPSY 129 0.0042
762 CONTUSION 406 0.0042
763 RESPIRATORY TRACT CONGESTION 67 0.0042
764 BONE DENSITY DECREASED 132 0.0042
765 BLOOD PRESSURE DECREASED 279 0.0042
766 ARTHRALGIA 1733 0.0042
767 GLOSSODYNIA 93 0.0041
768 DISEASE RECURRENCE 197 0.0041
769 SCIATICA 66 0.0041
770 STOMATITIS 251 0.0041
771 BRADYCARDIA 219 0.0041
772 PRURITUS 1583 0.0041
773 VIRAL INFECTION 137 0.0041
774 BLOOD PRESSURE INCREASED 628 0.0041
775 GINGIVAL BLEEDING 56 0.0041
776 TOOTH LOSS 85 0.0041
777 AGITATION 301 0.0041
778 SINUS DISORDER 81 0.0041
779 CYTOKINE RELEASE SYNDROME 82 0.0041
780 PAIN IN EXTREMITY 1201 0.0041
781 BLOOD URINE PRESENT 77 0.0041
782 PERICARDITIS 68 0.0040
783 TRANSIENT ISCHAEMIC ATTACK 136 0.0040
784 EAR INFECTION 107 0.0040
785 MULTIPLE FRACTURES 66 0.0040
786 DISCOMFORT 245 0.0040
787 DEPRESSED MOOD 212 0.0040
788 ABDOMINAL DISCOMFORT 672 0.0040
789 SYNOVITIS 72 0.0040
790 DELUSION 62 0.0040
791 DYSPNOEA 2254 0.0040
792 TYPE 2 DIABETES MELLITUS 134 0.0040
793 ORAL DISCOMFORT 55 0.0040
794 GASTRIC ULCER 75 0.0039
795 JOINT STIFFNESS 103 0.0039
796 BLOOD CREATINE PHOSPHOKINASE INCREASED 113 0.0039
797 VAGINAL HAEMORRHAGE 170 0.0039
798 ARTHRITIS 308 0.0039
799 BALANCE DISORDER 338 0.0039
800 ARRHYTHMIA 185 0.0039
801 PLATELET COUNT DECREASED 416 0.0039
802 EYE SWELLING 145 0.0039
803 THERAPEUTIC PRODUCT EFFECT DECREASED 174 0.0039
804 EYE PAIN 219 0.0039
805 BLOOD POTASSIUM INCREASED 63 0.0039
806 DIALYSIS 55 0.0039
807 APHONIA 54 0.0039
808 BLOOD TRIGLYCERIDES INCREASED 68 0.0038
809 DYSSTASIA 112 0.0038
810 ERUCTATION 74 0.0038
811 HEPATIC FUNCTION ABNORMAL 142 0.0038
812 TASTE DISORDER 77 0.0038
813 ACTIVITIES OF DAILY LIVING IMPAIRED 75 0.0038
814 MUSCLE SPASMS 692 0.0038
815 EMOTIONAL DISORDER 116 0.0038
816 PNEUMONITIS 102 0.0037
817 EXTRAPYRAMIDAL DISORDER 93 0.0037
818 HERPES ZOSTER 215 0.0037
819 NASAL CONGESTION 219 0.0037
820 MIGRAINE 355 0.0037
821 MUSCULOSKELETAL DISCOMFORT 64 0.0037
822 BASAL CELL CARCINOMA 58 0.0037
823 FATIGUE 2881 0.0037
824 INSOMNIA 974 0.0037
825 WEIGHT INCREASED 818 0.0036
826 SKIN DISCOLOURATION 167 0.0036
827 COLD SWEAT 64 0.0036
828 OXYGEN SATURATION DECREASED 204 0.0036
829 HYPERHIDROSIS 465 0.0036
830 JOINT SWELLING 435 0.0036
831 CARDIAC FAILURE CONGESTIVE 289 0.0036
832 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 645 0.0036
833 SEIZURE 413 0.0036
834 EPISTAXIS 266 0.0036
835 IMMUNODEFICIENCY 53 0.0036
836 PRODUCT USE COMPLAINT 56 0.0036
837 RHINORRHOEA 228 0.0035
838 DISEASE PROGRESSION 413 0.0035
839 TREATMENT NONCOMPLIANCE 190 0.0035
840 DISTURBANCE IN ATTENTION 187 0.0035
841 VISION BLURRED 475 0.0035
842 PSYCHOMOTOR HYPERACTIVITY 57 0.0034
843 VISUAL ACUITY REDUCED 114 0.0034
844 SUICIDAL IDEATION 314 0.0034
845 APATHY 50 0.0034
846 MOVEMENT DISORDER 110 0.0034
847 LOSS OF CONSCIOUSNESS 438 0.0034
848 PERIPHERAL SWELLING 526 0.0034
849 NEUTROPHIL COUNT DECREASED 139 0.0034
850 MEDICATION ERROR 189 0.0034
851 POOR QUALITY SLEEP 73 0.0034
852 DISABILITY 67 0.0034
853 HYPOTHYROIDISM 108 0.0034
854 BLOOD PRESSURE ABNORMAL 67 0.0034
855 MOBILITY DECREASED 242 0.0034
856 POLLAKIURIA 140 0.0034
857 SNEEZING 75 0.0033
858 COGNITIVE DISORDER 156 0.0033
859 MUSCLE TIGHTNESS 54 0.0033
860 PRURITUS GENERALISED 72 0.0033
861 KIDNEY INFECTION 65 0.0033
862 ARTHROPATHY 184 0.0033
863 COUGH 915 0.0033
864 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 76 0.0033
865 BONE PAIN 188 0.0032
866 RESTLESS LEGS SYNDROME 58 0.0032
867 RESPIRATORY DISORDER 94 0.0031
868 THIRST 56 0.0031
869 INTENTIONAL PRODUCT MISUSE 273 0.0031
870 CEREBRAL INFARCTION 76 0.0031
871 FLUSHING 314 0.0031
872 NIGHTMARE 106 0.0031
873 CEREBRAL HAEMORRHAGE 109 0.0030
874 ABASIA 75 0.0030
875 ASTHMA 342 0.0030
876 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 145 0.0030
877 VISUAL IMPAIRMENT 372 0.0030
878 ILLNESS 309 0.0030
879 ROAD TRAFFIC ACCIDENT 125 0.0030
880 SKIN EXFOLIATION 252 0.0030
881 SURGERY 175 0.0030
882 RENAL DISORDER 139 0.0030
883 FIBROMYALGIA 72 0.0030
884 LABORATORY TEST ABNORMAL 86 0.0029
885 GASTRIC DISORDER 100 0.0029
886 URINARY RETENTION 97 0.0029
887 WHITE BLOOD CELL COUNT DECREASED 315 0.0029
888 THROAT IRRITATION 130 0.0029
889 IRRITABILITY 174 0.0029
890 NASOPHARYNGITIS 529 0.0029
891 INFLUENZA 320 0.0029
892 RESPIRATORY ARREST 79 0.0029
893 HYPOACUSIS 123 0.0029
894 HIP FRACTURE 91 0.0028
895 LIMB INJURY 76 0.0028
896 PRODUCT USE ISSUE 525 0.0028
897 HERNIA 54 0.0028
898 FEELING ABNORMAL 669 0.0028
899 BLINDNESS 113 0.0028
900 ABNORMAL BEHAVIOUR 108 0.0027
901 PRODUCT PRESCRIBING ERROR 64 0.0027
902 MENORRHAGIA 52 0.0026
903 FALL 880 0.0026
904 COVID-19 458 0.0026
905 AGEUSIA 65 0.0026
906 SEDATION 68 0.0026
907 CARDIAC FAILURE 207 0.0026
908 DEVICE DISLOCATION 112 0.0026
909 AMNESIA 166 0.0025
910 INFLUENZA LIKE ILLNESS 208 0.0025
911 LACRIMATION INCREASED 75 0.0025
912 HOT FLUSH 187 0.0025
913 SYSTEMIC LUPUS ERYTHEMATOSUS 88 0.0025
914 CONTRAINDICATED PRODUCT ADMINISTERED 75 0.0025
915 FLUID RETENTION 125 0.0025
916 NERVOUSNESS 128 0.0024
917 UNEVALUABLE EVENT 184 0.0024
918 MOOD ALTERED 66 0.0024
919 TARDIVE DYSKINESIA 68 0.0024
920 HYPERSOMNIA 69 0.0024
921 INTENTIONAL DOSE OMISSION 68 0.0024
922 OSTEONECROSIS 78 0.0024
923 INTERSTITIAL LUNG DISEASE 114 0.0024
924 EYE PRURITUS 78 0.0023
925 ABNORMAL DREAMS 64 0.0023
926 DRUG EFFECT INCOMPLETE 84 0.0023
927 EYE DISORDER 75 0.0023
928 MEMORY IMPAIRMENT 313 0.0023
929 CATARACT 135 0.0023
930 DIABETIC KETOACIDOSIS 54 0.0022
931 HEAD INJURY 71 0.0022
932 DRY EYE 111 0.0022
933 ECZEMA 115 0.0022
934 ILL-DEFINED DISORDER 132 0.0022
935 PSORIASIS 282 0.0022
936 SUICIDE ATTEMPT 127 0.0021
937 ALOPECIA 407 0.0021
938 DEMENTIA 56 0.0020
939 RHEUMATOID ARTHRITIS 224 0.0020
940 MYOCARDIAL INFARCTION 343 0.0020
941 ACNE 146 0.0019
942 ACCIDENTAL OVERDOSE 70 0.0019
943 CEREBROVASCULAR ACCIDENT 318 0.0019
944 PLASMA CELL MYELOMA 72 0.0018
945 AGGRESSION 92 0.0018
946 THERAPEUTIC RESPONSE DECREASED 111 0.0018
947 MALIGNANT NEOPLASM PROGRESSION 185 0.0018
948 NEOPLASM PROGRESSION 62 0.0018
949 OVERDOSE 382 0.0018
950 SKIN BURNING SENSATION 126 0.0018
951 THERAPEUTIC RESPONSE UNEXPECTED 78 0.0017
952 PRODUCT DOSE OMISSION ISSUE 502 0.0017
953 DRY SKIN 224 0.0017
954 ADVERSE DRUG REACTION 150 0.0017
955 MOOD SWINGS 53 0.0017
956 OCULAR HYPERAEMIA 78 0.0016
957 DEVICE ISSUE 147 0.0016
958 DEVICE BREAKAGE 63 0.0016
959 INCORRECT DOSE ADMINISTERED 353 0.0015
960 HOSPITALISATION 237 0.0015
961 ANGER 52 0.0015
962 THERAPY CESSATION 78 0.0015
963 CARDIAC DISORDER 142 0.0015
964 EYE IRRITATION 87 0.0015
965 BLOOD GLUCOSE DECREASED 71 0.0015
966 MULTIPLE SCLEROSIS 70 0.0015
967 PRODUCT DOSE OMISSION 95 0.0015
968 NEOPLASM MALIGNANT 95 0.0014
969 PSORIATIC ARTHROPATHY 57 0.0014
970 BLOOD GLUCOSE INCREASED 258 0.0014
971 INTENTIONAL OVERDOSE 86 0.0013
972 DEATH 1085 0.0013
973 DRUG EFFECT DECREASED 67 0.0012
974 DERMATITIS ATOPIC 65 0.0012
975 UNDERDOSE 85 0.0012
976 INJECTION SITE PAIN 354 0.0012
977 ADVERSE EVENT 105 0.0011
978 SKIN IRRITATION 52 0.0011
979 INJECTION SITE BRUISING 88 0.0011
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 76 0.0011
981 INJECTION SITE ERYTHEMA 132 0.0011
982 THERAPY INTERRUPTED 75 0.0010
983 INJECTION SITE SWELLING 80 0.0010
984 INJECTION SITE PRURITUS 68 0.0010
985 INJECTION SITE REACTION 68 0.0010
986 COMPLETED SUICIDE 82 0.0010
987 INJECTION SITE HAEMORRHAGE 73 0.0009
988 DRUG DOSE OMISSION 149 0.0009
989 MULTIPLE SCLEROSIS RELAPSE 57 0.0008
990 PRODUCT QUALITY ISSUE 111 0.0008
991 DEVICE DIFFICULT TO USE 54 0.0008
992 NO ADVERSE EVENT 147 0.0008
993 DRUG WITHDRAWAL SYNDROME 65 0.0007
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 130 0.0006
995 DRUG DEPENDENCE 95 0.0006
996 BREAST CANCER 53 0.0006